Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Ferroptosis inducer-11

Catalog No. T213129 Copy Product Info
🥰Excellent
Ferroptosisinducer-11 is an agent that induces ferroptosis, exhibiting significant cytotoxicity against HCT-116, NCM-60, and HT-29 cells with IC50 values of 0.43 μM, 3.14 μM, and 0.48 μM, respectively. It potently inhibits GPX4 enzyme activity with an IC50 of 1.86 μM. This compound induces ferroptosis and increases lipid ROS, malondialdehyde (MDA), and Fe2+ levels in colon cancer cells while reducing glutathione (GSH) levels. Ferroptosisinducer-11 is useful for colon cancer research.

Ferroptosis inducer-11

Copy Product Info
🥰Excellent
Catalog No. T213129

Ferroptosisinducer-11 is an agent that induces ferroptosis, exhibiting significant cytotoxicity against HCT-116, NCM-60, and HT-29 cells with IC50 values of 0.43 μM, 3.14 μM, and 0.48 μM, respectively. It potently inhibits GPX4 enzyme activity with an IC50 of 1.86 μM. This compound induces ferroptosis and increases lipid ROS, malondialdehyde (MDA), and Fe2+ levels in colon cancer cells while reducing glutathione (GSH) levels. Ferroptosisinducer-11 is useful for colon cancer research.

Ferroptosis inducer-11
Pack SizePriceUSA StockGlobal StockQuantity
10 mgInquiryInquiryInquiry
50 mgInquiryInquiryInquiry
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Resource Download

Product Introduction

Bioactivity
Description
Ferroptosisinducer-11 is an agent that induces ferroptosis, exhibiting significant cytotoxicity against HCT-116, NCM-60, and HT-29 cells with IC50 values of 0.43 μM, 3.14 μM, and 0.48 μM, respectively. It potently inhibits GPX4 enzyme activity with an IC50 of 1.86 μM. This compound induces ferroptosis and increases lipid ROS, malondialdehyde (MDA), and Fe2+ levels in colon cancer cells while reducing glutathione (GSH) levels. Ferroptosisinducer-11 is useful for colon cancer research.
Targets&IC50
GPX4:1.86 μM
In vitro
Ferroptosis inducer-11 (Compound 30) demonstrates significant inhibitory activity on colony formation in HCT-116 colon cancer cells at concentrations of 0.25-1 μM over 24 hours. It exhibits potent cytotoxicity against HCT-116, NCM-60, and HT-29 cells, with IC 50 values of 0.43 μM, 3.14 μM, and 0.48 μM, respectively. In HCT-116 cells, Ferroptosis inducer-11 significantly increases lipid ROS levels in a time- and dose-dependent manner at 0.25-1 μM for 6-24 hours. It also elevates MDA levels, raises intracellular Fe 2+ levels, and decreases GSH levels in a dose-dependent manner at 0.25-1 μM over 12 hours. This compound strongly inhibits GPX4 with an IC 50 value of 1.86 μM and downregulates GPX4 protein expression in a time- and dose-dependent manner at 0.25-1 μM for 6-24 hours in HCT-116 cells.
Chemical Properties
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.

Citations

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy Ferroptosis inducer-11 | purchase Ferroptosis inducer-11 | Ferroptosis inducer-11 cost | order Ferroptosis inducer-11 | Ferroptosis inducer-11 in vitro